One of the most feared side effects of chemotherapy is peripheral neuropathy (CIPN). Unlike temporary side effects, neuropathy can sometimes cause lasting, life-altering changes that interfere with walking, writing, cooking, or even buttoning clothes.
What causes it?
Several chemotherapy drugs are known to cause nerve damage. The most common include:
- Taxanes (docetaxel, paclitaxel)
- Platinum drugs (oxaliplatin, cisplatin, carboplatin)
- Vinca alkaloids (vincristine)
- Proteasome inhibitors (bortezomib) among others
These medications can injure sensory nerves (responsible for touch, temperature, and pain), motor nerves (movement), and sometimes autonomic nerves (involuntary functions).
What are the symptoms?
Symptoms vary from person to person and depend on the drug and dose. Common ones include:
- Cold sensitivity (especially with oxaliplatin): pain or tingling when touching cold objects or swallowing cold liquids.
- Numbness, tingling, or burning pain in hands and feet, often in a “stocking-glove” pattern.
- Balance or coordination problems, making walking or fine tasks difficult.
Neuropathy often worsens with cumulative chemotherapy — the more cycles you receive, the higher the risk.
Can we prevent neuropathy?
Unfortunately, despite many clinical trials, no medication or supplement has been proven to reliably prevent CIPN.
Interventions studied without proven benefit:
Retinoic acid, amifostine, amitriptyline, calcium/magnesium, cannabinoids, carbamazepine, glutamine, glutathione, venlafaxine, vitamins B/E, omega-3 fatty acids, and others.
Important note: Acetyl-L-carnitine should not be used — it may actually worsen neuropathy.
What may help (but needs more study):
- Cryotherapy (cold gloves/socks): Some studies show reduced neuropathy rates, others don’t; safe if frostbite risk is managed.
- Compression therapy: Early studies suggest possible benefits.
- Exercise therapy: Growing evidence supports exercise for reducing symptom severity and improving function.
- Acupuncture: Small studies suggest benefit; larger trials are ongoing.
- GM-1 (ganglioside-monosialic acid): A Chinese trial showed benefit with taxanes, but confirmatory studies in broader populations are needed.
What if neuropathy develops?
If neuropathy occurs, your oncology team may adjust chemotherapy doses, delay treatment, or switch drugs.
Evidence-based treatment options:
- Duloxetine (Cymbalta): The only medication with strong evidence for reducing painful CIPN. It should be tapered gradually when stopped.
- Other possible options (less evidence): Gabapentin, pregabalin, tricyclic antidepressants, or topical gels with baclofen/amitriptyline. These may help some patients but are not universally effective.
- Non-drug options: Exercise, acupuncture, and physical therapy can help manage pain, balance, and overall function.
✅Key takeaway
Chemotherapy-induced neuropathy is common and can significantly affect quality of life. While no proven prevention exists yet, early recognition, communication with your oncology team, and targeted treatments like duloxetine can make a real difference. Supportive approaches such as exercise, acupuncture, and cryotherapy show promise but need further study.
Always let your care team know about symptoms you don’t have to suffer in silence
📚References:
- Loprinzi, C. L., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz, D. L., … Hershman, D. L. (2020). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. Journal of Clinical Oncology, 38(28), 3325–3348. https://doi.org/10.1200/JCO.20.01399
- Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., … Shapiro, C. L. (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial. JAMA, 309(13), 1359–1367. https://doi.org/10.1001/jama.2013.2813
- Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., … Loprinzi, C. (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline. Journal of Clinical Oncology, 32(18), 1941–1967. https://doi.org/10.1200/JCO.2013.54.0914
⚠️Legal Disclaimer:
This information is for educational purposes only and is not a substitute for personalized medical advice. Always follow your oncology team’s instructions and discuss any changes in your treatment plan with them.